160 related articles for article (PubMed ID: 2211123)
1. Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study.
Simon SL; Lloyd RD; Till JE; Hawthorne HA; Gren DC; Rallison ML; Stevens W
Health Phys; 1990 Nov; 59(5):669-91. PubMed ID: 2211123
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
[TBL] [Abstract][Full Text] [Related]
3. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report.
Rallison ML; Lotz TM; Bishop M; Divine W; Haywood K; Lyon JL; Stevens W
Health Phys; 1990 Nov; 59(5):739-46. PubMed ID: 2211127
[TBL] [Abstract][Full Text] [Related]
4. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
[TBL] [Abstract][Full Text] [Related]
5. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
[TBL] [Abstract][Full Text] [Related]
6. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
Wachholz BW
Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
[TBL] [Abstract][Full Text] [Related]
7. Models of radioiodine transport to populations within the continental U.S.
Bouville A; Dreicer M; Beck HL; Hoecker WH; Wachholz BW
Health Phys; 1990 Nov; 59(5):659-68. PubMed ID: 2145245
[TBL] [Abstract][Full Text] [Related]
8. Pasture practices, milk distribution, and consumption in the continental U.S. in the 1950s.
Dreicer M; Bouville A; Wachholz BW
Health Phys; 1990 Nov; 59(5):627-36. PubMed ID: 2211120
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests.
Gilbert ES; Tarone R; Bouville A; Ron E
J Natl Cancer Inst; 1998 Nov; 90(21):1654-60. PubMed ID: 9811315
[TBL] [Abstract][Full Text] [Related]
10. Testing prediction capabilities of an 131I terrestrial transport model by using measurements collected at the Hanford nuclear facility.
Apostoaei AI
Health Phys; 2005 May; 88(5):439-58. PubMed ID: 15824593
[TBL] [Abstract][Full Text] [Related]
11. Individual external exposures from Nevada Test Site fallout for Utah leukemia cases and controls.
Lloyd RD; Gren DC; Simon SL; Wrenn ME; Hawthorne HA; Lotz TM; Stevens W; Till JE
Health Phys; 1990 Nov; 59(5):723-37. PubMed ID: 2211126
[TBL] [Abstract][Full Text] [Related]
12. The assessment of radiation exposures in Native American communities from nuclear weapons testing in Nevada.
Frohmberg E; Goble R; Sanchez V; Quigley D
Risk Anal; 2000 Feb; 20(1):101-11. PubMed ID: 10795343
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer risk in the population around the Nevada Test Site.
Zeighami EA; Morris MD
Health Phys; 1986 Jan; 50(1):19-32. PubMed ID: 3943971
[TBL] [Abstract][Full Text] [Related]
14. Ingestion of Nevada Test Site fallout: internal dose estimates.
Whicker FW; Kirchner TB; Anspaugh LR; Ng YC
Health Phys; 1996 Oct; 71(4):477-86. PubMed ID: 8830749
[TBL] [Abstract][Full Text] [Related]
15. Nevada test fallout and radioiodine in milk.
LAPP RE
Science; 1962 Sep; 137(3532):756-8. PubMed ID: 14462359
[TBL] [Abstract][Full Text] [Related]
16. Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests.
Hundahl SA
CA Cancer J Clin; 1998; 48(5):285-98. PubMed ID: 9742895
[TBL] [Abstract][Full Text] [Related]
17. Milk distribution and feeding practice data for the PATHWAY model.
Ward GM; Whicker FW
Health Phys; 1990 Nov; 59(5):637-43. PubMed ID: 2211121
[TBL] [Abstract][Full Text] [Related]
18. The Utah Leukemia Case-Control Study: dosimetry methodology and results.
Simon SL; Till JE; Lloyd RD; Kerber RL; Thomas DC; Preston-Martin S; Lyon JL; Stevens W
Health Phys; 1995 Apr; 68(4):460-71. PubMed ID: 7883558
[TBL] [Abstract][Full Text] [Related]
19. A post-Chernobyl rise in thyroid cancer in Connecticut, USA.
Mangano JJ
Eur J Cancer Prev; 1996 Feb; 5(1):75-81. PubMed ID: 8664814
[TBL] [Abstract][Full Text] [Related]
20. Historical estimates of external gamma exposure and collective external gamma exposure from testing at the Nevada Test Site. II. Test series after Hardtack II, 1958, and summary.
Anspaugh LR; Ricker YE; Black SC; Grossman RF; Wheeler DL; Church BW; Quinn VE
Health Phys; 1990 Nov; 59(5):525-32. PubMed ID: 2211112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
